For the purpose of assessing clinical improvements, follow up times were grouped into time periods of 3–6 months, 7–9 months, 10–13 months and greater than 13 months.

Most of the patients experienced an improving trend in clinical symptoms within 9 months after the first treatment, and a small number of patients with poor initial treatments presented with improved clinical symptoms during the 10–30 months after treatment.